Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-31

Clinical Trial Update: The Safety and Effectiveness of Rifabutin, Combined With Clarithromycin or Azithromycin, in HIV-Infected Patients [NA]

View source ↗

Summary

This update reports results from a completed trial assessing the safety and effectiveness of rifabutin when combined with either clarithromycin or azithromycin …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)
  • RIFABUTIN (Rifabutin)
  • clarithromycin (clarithromycin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Mycobacterium Avium-intracellulare Infection, HIV Infections | NA | Status: COMPLETED